The post Bitso Adopts XRP & RLUSD to Boost Cross-Border Payments appeared on BitcoinEthereumNews.com. Bitso Taps Ripple, XRP, and RLUSD to Supercharge Cross-BorderThe post Bitso Adopts XRP & RLUSD to Boost Cross-Border Payments appeared on BitcoinEthereumNews.com. Bitso Taps Ripple, XRP, and RLUSD to Supercharge Cross-Border

Bitso Adopts XRP & RLUSD to Boost Cross-Border Payments

Bitso Taps Ripple, XRP, and RLUSD to Supercharge Cross-Border Payments in Latin America

Bitso is expanding its global footprint by accelerating cross-border payments in Latin America using Ripple Payments, XRP, and RLUSD, positioning itself at the forefront of faster, lower-cost, and more transparent international transactions for businesses.

Well, cross-border payments in Latin America have historically been plagued by high fees, slow settlement, and poor transparency, largely due to reliance on multiple intermediary banks that add delays and unpredictable costs. 

Gabriele Zuliani, Bitso’s Head of Growth, welcomed the move saying:

Bitso Business is tackling these issues by integrating Ripple’s blockchain-powered payments infrastructure and digital assets into its B2B flows, enabling faster, more transparent, and cost-efficient transactions.

By leveraging Ripple Payments with XRP as a bridge asset, Bitso can settle cross-border transactions on blockchain rails in near real time. 

Rather than parking capital in pre-funded foreign accounts, funds can be moved and converted on demand, lowering capital needs, boosting liquidity efficiency, and shrinking settlement times from days to minutes.

Meanwhile, Ripple has effectively removed the final barrier for banks on the XRP Ledger (XRPL), a development many view as bullish and capable of unlocking billions in potential institutional flows.

How Bitso and RLUSD Are Transforming Remittances and Business Payments in Latin America

RLUSD sits at the center of this strategy, a regulated, dollar-backed stablecoin built to deliver transparent, dependable liquidity. 

By leveraging RLUSD, Bitso can enable stable digital-dollar settlements that avoid the sharp price swings common in many crypto assets. This is especially valuable in Latin America, where local currency volatility often increases the cost and risk of cross-border payments.

Binance recently listed Ripple’s dollar-backed stablecoin RLUSD, a milestone that boosts Ripple’s global reach and cements its position in the stablecoin market.

RLUSD-based settlement streamlines two key regional needs: remittances and payments in volatile local currencies. It enables faster, lower-cost cross-border transfers so recipients keep more of what’s sent, while giving businesses multi-currency predictability and simpler reconciliation through stable, on-chain settlement.

Interestingly, Bitso has transformed from a crypto exchange into a full-scale B2B money movement platform, now powering high-demand payment corridors between the U.S. and Latin America, one of the world’s busiest remittance and trade routes. 

With clearer stablecoin regulations and rising institutional appetite for compliant digital dollars, Bitso is strategically positioned to distribute and enable payouts for RLUSD across the region.

By leveraging Ripple Payments, XRP, and RLUSD, Bitso offers a modern cross-border stack that delivers faster settlement, lower costs, and greater reliability, giving Latin American businesses a stronger edge in a global, digital-first economy.

Conclusion

Bitso is transforming cross-border finance in Latin America through Ripple Payments, XRP, and RLUSD, offering businesses near-instant, low-cost, and transparent transactions. 

With RLUSD providing stable, regulated dollar liquidity, Bitso is set to lead the next wave of compliant, blockchain-powered international payments, making global transactions faster, simpler, and more reliable than ever.

Source: https://coinpaper.com/14437/ripple-breakthrough-top-latin-american-platform-embraces-xrp-and-rlusd-for-faster-global-transfers

Market Opportunity
CROSS Logo
CROSS Price(CROSS)
$0.10333
$0.10333$0.10333
+0.86%
USD
CROSS (CROSS) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26